Posts Tagged ‘Intestine’

Pseudomembranous Colitis

04.16.10

Pseudomembranous colitis is an infection of the colon often, but not always, caused by the bacterium Clostridium difficile. Still, the expression “C. diff colitis” is used almost interchangeably with the more proper term of pseudomembranous colitis.

The illness is characterized by offensive-smelling diarrhea, fever, and abdominal pain. It can besevere,causing toxic megacolon, or even fatal. The use of broad-spectrum antibiotics such as clindamycin and cephalosporins causes the normal bacterial flora of the bowel to be altered. In particular, when the antibiotic kills off other, competing bacteria in the intestine, any bacteria remaining will have less competition for space and nutrients there.

The net effect is to permit much more extensive growth than normal of certain bacteria. Clostridium difficile is one such type of bacterium. In addition to proliferating in the bowel, the C. diff also elaborates a toxin. It is this toxin that is responsible for the diarrhea which characterizes pseudomembranous colitis. n most cases a patient presenting with pseudomembranous colitis has recently been on antibiotics.

Antibiotics disturb the normal bowel bacterial flora. Clindamycin is the antibiotic classically associated with this disorder, but any antibiotic can cause the condition. Even though they are not particularly likely to cause pseudomembranous colitis, due to their very frequent use cephalosporin antibiotics (such as cefazolin and cephalexin) account for a large percentage of cases.

Diabetics and the elderly are also at increased risk, although half of cases are not associated with risk factors. Other risk factors include increasing age and recent major surgery. There is some evidence that proton pump inhibitors are a risk factor for pseudomembranous colitis, but others question whether this is a false association or statistical artifact (increased PPI use is itself a marker of increased age and co-morbid illness).; indeed, one large case-controlled study showed that PPI’s are not a risk factor.

Recently, evidence has emerged to suggest that the use of ciprofloxacin (in addition to a primary causative antibiotic such as clindamycin) is associated with increased mortality in patients with pseudomembranous colitis.)

As noted above, pseudomembranous colitis is characterized by diarrhea, abdominal pain, and fever. Usually, the diarrhea is non-bloody, although blood may be present if the affected individual is taking blood thinners or has an underlying lower bowel condition such as hemorrhoids. Abdominal pain is almost always present and may be severe.

So-called “peritoneal” signs (e.g. rebound tenderness) may be present. “Constitutional” signs such as fever, fatigue, and loss of appetite are prominent. In fact, one of the main ways of distinguishing pseudomembranous colitis from other antibiotic-associated diarrheal states is that patients with the former are sick.

That is, they are often prostrate, lethargic, and generally look unwell. Their “sick” appearance tends to be paralleled by the results of their blood tests which often show anemia, an elevated white blood cell count, and low serum albumin.

Possibly related posts: (automatically generated)

Crohns Disease Surgery

01.08.10

Two-thirds to three-quarters of patients with Crohn’s disease will require surgery at some point during their lives. Surgery becomes necessary in Crohn’s disease when medications can no longer control the symptoms. It may also be performed to repair a fistula or fissure.

Another indication for surgery is the presence of an intestinal obstruction or other complication, such as an intestinal abscess. In most cases, the diseased segment of bowel and any associated abscess is removed; this is called a resection. The two ends of healthy bowel are then joined together in a procedure called an anastomosis. While resection and anastomosis may allow many symptom-free years, this surgery is not considered a cure for Crohn’s disease, because the disease frequently recurs at or near the site of anastomosis.

An ileostomy also may be required when surgery is performed for Crohn’s disease of the colon. After the surgeon removes the colon, he brings the small bowel to the skin, so that waste products may be emptied into a pouch attached to the abdomen. This procedure is needed if the rectum is diseased and cannot be used for an anastomosis.

The overall goal of surgery in Crohn’s disease is to conserve bowel and return the individual to the best possible quality of life. Surgery does not cure Crohn’s disease, but corrects an immediate problem that cannot be resolved using medication. Four types of surgery are commonly performed on individuals with Crohn’s disease:
•    Partial bowel resection, to remove a diseased portion of intestine
•    Strictureplasty
•    Correction of fistulas
•    Draining of an abscess

It is estimated that about 75% of individuals who live with Crohn’s disease will require surgery at some point in their lives, and that 75% of those who have one surgery will need at least one subsequent surgery.

Partial Bowel Resection
Resection is usually performed when a portion of intestine has been so damaged by disease that a permanent partial obstruction has formed. The most common areas removed are the terminal ileum, the ileocecal valve, and a small portion of the large intestine. Usually, the surgeon will attach (anastomose) the healthy ends of intestine together during the procedure.

Sometimes, however, there is mild inflammation throughout the intestine, preventing such reattachment. In these cases, a temporary ostomy is created. The ostomy allows intestinal contents to drain directly out of the body into a collecting bag through the abdominal wall. The ostomy is usually closed and the bowel reattached six to eight weeks after the initial surgery.After surgery, disease tends to occur above

Possibly related posts: (automatically generated)

Crohns Disease Drugs

09.21.09

Thirty-two years ago Ginger Gray walked into her doctor’s office complaining of abdominal pain, diarrhea, severe weight loss, and overwhelming joint pain. At 19, she hadn’t grown an inch since the sixth grade. But her doctor said there was nothing physically wrong with her, and even suggested she seek psychiatric counseling.

Fortunately for Gray, she sought another physician’s opinion.

Based on tests he conducted, the doctor recommended the 4-foot-11-inch Pennsylvania resident begin full-time treatment for Crohns disease.”Crohns disease robbed me of my stamina,” Gray says. “It took two years for me to fully regain my strength and weight so that I could begin working again.”Until now, treatment for Crohn’s has relied on surgery and anti-inflammatory and other drugs also used to treat other conditions.

In August 1998, the Food and Drug Administration licensed the first treatment specifically for Crohns disease, an incurable and sometimes debilitating inflammation of the bowel.Remicade (infliximab) is a genetically engineered antibody that blocks inflammation caused by a protein called tumor necrosis factor. After clinical trials showed benefit from Remicade treatment within a two-to-four week period following a single dose, FDA approved the drug for patients with moderate to severe Crohns disease who have not found relief with other treatments.

“We recognized that [Remicade] had such a dramatic effect on patients,” says Barbara Matthews, M.D., a medical officer in FDA’s Center for Biologics Evaluation and Research, “that it was given accelerated approval.”Remicade, which is taken intravenously, can decrease the amount of inflammation along the lining of the intestine.

Clinical trials also show that Remicade is effective in closing fistulas (abnormal passages or sores between the bowel and skin). Although not a cure, the drug reduces the symptoms in patients who have not responded well to traditional treatments.”This is an exciting development for two reasons,” says R. Balfour Sartor, M.D., professor of medicine, microbiology and immunology at the University of North Carolina, and chairman of the National Scientific Advisory Committee for the Crohn’s & Colitis Foundation of America (CCFA). “It is the first therapy for Crohns disease derived by molecular techniques, and it has the possibility of improving the quality of life for [Crohn's] patients.”

But Sartor also cautions that the long-term toxic effects of Remicade are unknown and that the drug is not needed by every Crohns disease patient. “Two-thirds of the people will have near immediate results,” he says, “but only those patients who do not respond to other therapies” are eligible to take the drug. The next step is to maintain a patient’s remission after the drug’s initial effect has worn off.

Currently, studies are being done to better define the risks and longer-term benefits of Remicade because drug reactions and potential adverse effects from suppressing tumor necrosis factor require further clarification. Crohns disease is one of two major types of inflammatory bowel diseases (IBD)–the general term for diseases that cause inflammation in the intestines–and has no cure and a high rate of recurrence following treatment.

It usually occurs in the lowest portion of the small intestine (ileum), and the large intestine (colon or bowel), but it can occur in other parts of the digestive tract. Crohn’s usually involves all layers of the intestinal wall.

The disease can be difficult to diagnose because its symptoms, which include chronic diarrhea, crampy abdominal pain, loss of appetite, and weight loss, often mimic those of the other IBD type–ulcerative colitis–which affects only the colon. (See “Is It Crohn’s Disease?”)

Possibly related posts: (automatically generated)

Crohns Disease Foods

08.12.09

Although diet cannot cause or cure Crohns disease, some studies suggest that people who eat foods high in saturated fat and sugar or who eat processed foods may be more likely to develop the disease. Certain foods may also reduce symptoms and make recurrences of the disease less likely.

•    Eating fruits and vegetables, lowering fat, and eliminating sugar may reduce the risk of developing Crohns disease. Although a low-fiber diet is one of the risk factors for developing Crohns disease, some people with Crohns disease find that fiber makes symptoms worse. If fiber bothers you, steam or bake your vegetables rather than eating them raw, and avoid high fiber fruits such as apples.

•    Certain foods may aggravate symptoms of Crohns disease – most often, dairy products, fats, and spicy foods. People with Crohns disease may want to avoid these foods.

•    Eat five or six small meals a day.

•    If symptoms are severe, an elemental diet may be recommended. Elemental formulas are liquid diets that contain only the basic building blocks of food and need not be broken down into smaller substances along the digestive tract.

Some people find it difficult to stick to an elemental diet, but after a period of time, often other foods can be reintroduced. One study suggests that adding omega-3 fatty acids to an elemental diet may boost its nutritional content and make it more likely that people with Crohns disease will adhere to it.

Because of decreased appetite, malabsorption, chronic diarrhea, side effects of medication, and surgical removal of parts of the digestive tract, many people with Crohns disease have vitamin and mineral deficiencies. In particular, people with Crohns disease may lack adequate vitamin D, B12, and K, plus folic acid, calcium, and zinc. Your doctor may recommend that you take a multivitamin daily.  Zinc (25 mg), folic acid (800 mcg), vitamin B12 (800 mcg) — These vitamins are used by the body to repair cells in the intestine.

In addition, drugs such as sulfasalazine and methotrexate may case levels of folic acid in the body to drop, requiring supplementation. Vitamin D (1,000 IU per day) — is necessary to maintain strong bones. People with Crohns disease, especially those who take corticosteroids, often have low levels of vitamin D and are at risk for osteoporosis.  Fish oil (2.7 g per day) — Omega-3 fatty acids found in fish oil may help fight inflammation and reduce the chances of recurrence, but studies have been mixed. The study with the most positive results used a special type of fish oil – “enteric-coated free-fatty-acid form” – that is not sold commercially.

Some researchers suggest that measuring the blood levels of different types of fatty acids may help determine if fish oil would be useful. Do not take high doses of a fish oil supplement if you take blood-thinning medication.

Possibly related posts: (automatically generated)

Alternative Crohns Disease Treatment

05.17.09

The main treatment for Crohns disease is medicine to stop the inflammation in the intestine and medicine to prevent flare-ups and keep you in remission. A few people have severe, persistent symptoms or complications that may require a stronger medicine, a combination of medicines, or surgery.

The type of symptoms you have and how bad they are will determine the treatment you need. Aminosalicylates (such as sulfasalazine or mesalamine). These medicines help manage symptoms for many people who have Crohns disease. Antibiotics such as ciprofloxacin and metronidazole may be tried if aminosalicylates are not helping your symptoms. These medicines work especially well for disease in the colon.

Antibiotics are also used to treat fistulas, which are abnormal connections or openings between two organs or parts of the body. But 50% of fistulas come back when antibiotics are stopped. Corticosteroids (such as budesonide or prednisone) may be given by mouth for a few weeks or months to control inflammation. But corticosteroids have serious side effects, such as high blood pressure, osteoporosis, and increased risk of infection. Budesonide causes remission in mild or moderate Crohns disease of the ileum and the right colon. It does not work as well as prednisone or other corticosteroids. But it also does not have as many side effects as other corticosteroids. The long-term side effects are not well known, so your doctor will probably not have you take it for a long time.

Prednisone may help if budesonide does not. Medicines that suppress the immune system (called immunomodulator medicines), such as azathioprine (AZA), 6-mercaptopurine (6-MP), or methotrexate. You may take these if the medicines listed above do not work, if your symptoms come back when you stop taking corticosteroids, or if your symptoms come back often, even with treatment.

If you have tried all the medicines listed above and none of them have worked, your doctor may give you a tumor necrosis factor (TNF) antagonist such as infliximab (Remicade). This drug may work for people who have not had any success with other medicines for Crohns disease. Infliximab is also used to treat fistulas if antibiotics do not heal them. Another TNF antagonist that may be used to treat Crohns disease is adalimumab (Humira). It may work for people for whom infliximab has stopped working and for people who have a bad reaction to infliximab.

Possibly related posts: (automatically generated)

Can Viagra Help Crohns Disease

05.14.09

While well known for its effect on blood flow, until now Viagra has not been used to boost circulation in the intestine. That could change with the finding that Viagra can help treat Crohns disease. People with the long-term, inflammatory condition develop holes and ulcers in the intestine.

A team from University College London wondered whether an overactive immune reaction was the problem.The team carried out biopsies on six Crohns disease patients and nine healthy volunteers. The operation triggered an acute immune response in the healthy people, producing white blood cells to heal damage caused by the removal of cells. But the Crohn’s patients responded by producing far lower amounts of white blood cells. The researchers used Viagra to boost blood flow to the intestine in the patients with Crohns disease, thus increasing the flow of white cells to the damaged area.

Researchers in the U.K. have a new theory to explain the cause of Crohns disease, and they say medications like the erectile dysfunction drug Viagra may prove useful for treating the bowel disorder if they are right.In Crohns disease, chronic inflammation causes ulcers within the digestive tract that can lead to severe gastrointestinal symptoms, including abdominal pain, persistent diarrhea, and rectal bleeding.The most widely accepted theory is that an overactive immune system causes the damaging inflammation.

But researchers from the University College London say the opposite appears to be true.They believe a weaker-than-normal immune response triggers the bowel inflammation that leads to Crohns disease. The researchers tested this theory by treating 10 Crohn’s patients with 50 milligrams of Viagra after injecting them with the killed gut bacteria. They found that blood flow to the infected area improved.

“Increasing blood flow is an important part of the inflammatory response, and that is why this drug may work,” Segal says. “But we don’t yet know if this will give rise to successful treatment. We need to study this further to find out.” The disease usually affects the small intestine and one in every thousand people in the UK is afflicted with this miserable complaint.

But now scientists believe they have found the cause of Crohns disease, and they think it could be treated with Viagra.The team of researchers from University College London say they believe the cause is the opposite of what has been supposed and is triggered by a weak immune system, rather than an overactive one where cells are attacked by the body’s own immune system.

Crohn’s was previously thought to be an auto-immune disease and was treated with immuno-suppressant drugs. But the researchers led by Anthony Segal and colleagues have discovered that people with Crohn’s have a weak and unresponsive immune system which does not repair damage easily. They say the flow of blood to damaged cells is substantially reduced, and a drug such as Viagra, best known for its effects on erectile dysfunction, could help the healing process as it stimulates blood flow.

Since it was identified in the 1920s there have been many theories as to the cause of Crohn’s and it was often compared with tuberculosis, but attempts to find an infectious agent have failed.
The research team compared the immune system response of Crohn’s patients and healthy individuals to minor injuries, such as skin abrasions and discovered a difference in the number of white blood cells called neutrophils produced by the body to heal the damage in the bowel and on the surface of the skin.

Possibly related posts: (automatically generated)